Tag: Co-Commercialisation
Sidley guides USD2.1bn Telix radiopharmaceutical collaboration
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
Sidley Austin advises Australia-based Telix Pharmaceuticals on its USD2.1 billion strategic collaboration with American biotech Regeneron
As investment flows into infrastructure, renewables and emerging technologies, project finance continues to evolve
Follow us on LinkedIn